Acanthamoeba and bacteria produce antimicrobials to target their counterpart

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Iqbal, Junaid ^a   Siddiqui, Ruqaiyyah ^a   Khan, Naveed Ahmed ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; ANTIINFECTIVE AGENT; CULTURE MEDIUM;

ACANTHAMOEBA; BACTERIUM; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY;

ACANTHAMOEBA; AMEBICIDES; ANTI-INFECTIVE AGENTS; BACTERIA; CULTURE MEDIA, CONDITIONED; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY;

EID: 84893180838     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-56     Document Type: Article

References (23)

1. World Health Organization, Mortality Report 2002 Available at http://www.who.org
2. Resistance to antibiotics: are we in the post-antibiotic era? Alanis AJ, Arch Med Res 2005 36 697 705 10.1016/j.arcmed.2005.06.009 16216651 (Pubitemid 41436239)
3. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Nordmann P, Naas T, Fortineau N, Poirel L, Curr Opin Microbiol 2007 10 436 440 10.1016/j.mib.2007.07.004 17765004 (Pubitemid 350064580)
4. Newer antibacterial drugs for a new century. Devasahayam G, Scheld WM, Hoffman PS, Expert Opin Investig Drugs 2010 19 215 234 10.1517/13543780903505092 20053150
5. Natural products-the future scaffolds for novel antibiotics? Butler MS, Buss AD, Biochem Pharmacol 2006 71 919 929 10.1016/j.bcp.2005.10.012 16289393
6. Antibiotics: natural products essential to human health. Demain AL, Med Res Rev 2009 29 821 842 10.1002/med.20154 19291695
7. Cockroaches and locusts: physicians' answer to infectious diseases. Lee S, Duce I, Atkins H, Khan NA, Int J Antimicrob Agents 2011 37 279 280 10.1016/j.ijantimicag.2010.12.005 21269810
8. The story of penicillin. Fleming A, Am Inst Homeopath 1946 39 154 157
9. Agro active compounds of microbial origin. Tanaka YT, Mura SO, Annu Rev Microbiol 1993 47 57 87 10.1146/annurev.mi.47.100193.000421 8257109
10. Ecology of Acanthamoeba. De Jonckheere JF, Rev Infect Dis 1991 13 Suppl 5 385 S387 2047667
11. Khan NA, Acanthamoeba Biology and Pathogenesis Norfolk, UK: Caister Academic Press 2009
12. Microorganisms resistant to free-living amoebae. Greub G, Raoult D, Clin Microbiol Rev 2004 17 413 433 10.1128/CMR.17.2.413-433.2004 15084508 (Pubitemid 38534035)
13. War of the microbial worlds: who is the beneficiary in Acanthamoeba-bacterial interactions? Siddiqui R, Khan NA, Exp Parasitol 2012 130 311 313 10.1016/j.exppara.2012.01.021 22348931
14. Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii. Tamang MD, Kim S, Kim SM, Kong HH, Kim J, J Microbiol 2011 49 841 846 10.1007/s12275-011-1063-8 22068504
15. Pseudomonas aeruginosa uses type III secretion system to kill biofilm-associated amoebae. Matz C, Moreno AM, Alhede M, Manefield M, Hauser AR, Givskov M, Kjelleberg S, ISME J 2008 2 843 852 10.1038/ismej.2008.47 18480848
16. Predator-prey chemical warfare determines the expression of biocontrol genes by rhizosphere-associated Pseudomonas fluorescens. Jousset A, Rochat L, Scheu S, Bonkowski M, Keel C, Appl Environ Microbiol 2010 76 5263 5268 10.1128/AEM.02941-09 20525866
17. Acanthamoeba castellanii is a potential environmental host for Enterobacter aerogenes and Aeromonas hydrophila. Yousuf FA, Siddiqui R, Khan NA, Parasit Vectors 2013 6 169 10.1186/1756-3305-6-169 23742105
18. The role of Src kinase in the biological properties of Acanthamoeba. Siddiqui R, Iqbal J, Maugeuret M, Khan NA, Parasit Vectors 2012 5 112 10.1186/1756-3305-5-112 22676352
19. Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Sissons J, Kim KS, Stins M, Jayasekera S, Alsam S, Khan NA, Infect Immun 2005 73 2704 2708 10.1128/IAI.73.5.2704-2708.2005 15845472 (Pubitemid 40570335)
20. Neuropathogenic Escherichia coli K1 does not exhibit proteolytic activities to exert its pathogenicity. Iqbal J, Rajani M, Siddiqui R, Khan NA, J Negat Results Biomed 2013 12 8 10.1186/1477-5751-12-8 23634997
21. Staphylococcus aureus exhibit similarities in their interactions with Acanthamoeba and ThP1 macrophage-like cells. Cardas M, Khan NA, Alsam S, Exp Parasitol 2012 132 513 518 10.1016/j.exppara.2012.08.014 23000484
22. In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype. Baig AM, Iqbal J, Khan NA, Antimicrob Agents Chemother 2013 57 3561 3567 10.1128/AAC.00299-13 23669391
23. What is MRSA? Pantosti A, Venditti M, Eur Respir J 2009 34 1190 1196 10.1183/09031936.00007709 19880619